Benitec Biopharma Inc. (BNTC) stock forecast and price target
Price $9.04 · data as of November 13, 2026
12-month price target
Average target$23.32
Upside / downside+158.0%
Analysts7
ConsensusStrong buy
Low $17.00Average $23.32High $32.00
Gold marker: average target · white marker: today’s price ($9.04)
Analyst ratings
Strong buy 2Buy 6Hold 0Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends June 30, 2027 | $-1.19 | — | $0 |
| Next fiscal year ends June 30, 2028 | $-1.44 | — | $0 |
| Next quarter ends December 31, 2026 | $-0.29 | — | $0 |
| Quarter after ends March 31, 2027 | $-0.31 | — | $0 |
Consensus of the analysts covering Benitec Biopharma, updated daily. In the last 30 days 0 estimates were raised and 3 lowered.
Frequently asked questions
What is the Benitec Biopharma stock price target?
The average 12-month target from 7 analysts is $23.32, 158.0% above the current price of $9.04 Targets range from $17.00 to $32.00.
Is Benitec Biopharma a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 6 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Benitec Biopharma expected to earn?
Analysts expect EPS of $-1.19 for the fiscal year ending June 30, 2027 and $-1.44 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.